News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sepracor, Inc. (SEPR) Release: BROVANA(TM) (Arformoterol Tartrate) Inhalation Solution Study Data Presented At American College of Chest Physicians Annual Conference



10/23/2006 1:01:48 PM

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sepracor Inc. (Nasdaq: SEPR) today announced that it presented data from a Phase III pivotal trial of BROVANA™ (arformoterol tartrate) Inhalation Solution at CHEST 2006, the annual meeting of the American College of Chest Physicians (ACCP), in Salt Lake City.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES